Santos da Silva Jorge 4
4 · MoonLake Immunotherapeutics · Filed Dec 10, 2025
Insider Transaction Report
Form 4
Santos da Silva Jorge
DirectorChief Executive Officer
Transactions
- Sale
Class A ordinary shares, par value $0.0001 per share
2025-12-08$15.08/sh−130,000$1,960,400→ 2,948,577 total - Sale
Class A ordinary shares, par value $0.0001 per share
2025-12-09$14.49/sh−70,000$1,014,300→ 2,878,577 total
Footnotes (2)
- [F1]Sales made pursuant to Rule 144 under the Securities Act of 1933, as amended, to cover tax liabilities of the Reporting Person and other expenses incurred related to the sales.
- [F2]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $15.045789 to $15.098641. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.